H1 in the News

H1. was born out of the premise that the enormous wealth of scholarly and clinical data should be harnessed by the people who produce and fund it. Scholarly publications, clinical trials, patents, and conference activity, when aggregated and attributed to the correct authors and contact information, can lead to profound analytics. H1.’s result is an evolving, interconnected archive of the drugs…Read More